Status:
NOT_YET_RECRUITING
Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Hepatic Fibrosis
Eligibility:
All Genders
18-70 years
Brief Summary
Liver fibrosis screening is possible at the asymptomatic stage through a healthcare management strategy currently recommended for patients with risk factors for chronic liver disease. It is based on a...
Eligibility Criteria
Inclusion
- Patients between 18 and 70 years of age
- FIB-4 2.67
- Patients covered by Health Insurance System
Exclusion
- Prescription triggering FIB-4 emanate from a hepatogastroenterologist or oncologist
- Conditions associated with high risk false-positive FIB-4: ASAT or ALAT \> 300 IU/L, platelets \<50 G/L or \>500 G/L.
- Patient refusing to participate
- Subjects under guardianship or deprived of liberty
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06119997
Start Date
June 1 2025
End Date
July 30 2027
Last Update
April 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.